And they would pick up the pipeline and related technology to say nothing of the billions in write-offs.So what are they waiting on?
Imho If JNJ doesn't then a smart competitor such as BMY or any number of others will.It will be too bad for us as there is great potential in this drug and it's technology to say nothing of the tax benefits that are great enough to pay for the purchase.We could own all that for nothing.
I am pretty certain BP realizes that. Could very well be considering applying DNDN technologies to many other types of cancers. DNDN technology and experience in this area could be invaluable. That is IMHO the best reason to acquire DNDN,Provenge is an added bonus.